image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

Bovis

March 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BVS
  • Price:
  • 851p
Bovis issued a disappointing update, noting that due to production delays and the deferral of 180 completions into 2017, it now anticipates full year results to be below expectations. It previously expected c. 5% growth in completions but that will now be 0-2%. Average sales prices of completions in 2016 are expected to increase by around 10%, driven by an improved mix and increased market pricing. As a result pretax profit forecasts are now expected to be £160m-£170m, down from £185m previously.Numis has left 2017 estimates unchanged at £196m pretax profit and claims Bovis is in a more solid position to deliver because of 1.) those 180 deferred homes should be delivered early 2017, 2.) Bovis now has all lan ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Bovis Homes (September 2019)
Bovis Homes - Sales per site +15.7% in first 8 weeks (April 2019)
Bovis Homes (March 2019)
Bovis Homes (November 2018)
Bovis Homes (September 2018)
Bovis Homes - 102p dividend forecast for this year (April 2018)
Bovis (January 2018)
Bovis (November 2017)
Bovis - New CEO acquires £3.2m shareholding in housebuilder (August 2017)
Bovis (May 2017)
Bovis - Shares make strong recovery (October 2016)
Bovis - Weekly sales rates improve (July 2016)
Bovis - Price target 1322p (April 2016)
Bovis Homes - House builder targets 50% increase in output; price target 1588p (March 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X